Gregg C Fonarow

Gregg C Fonarow

Professor and Clinical Co-Chief of Cardiology

Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center, Los Angeles, California, US

  • X
  • OrcidID

Biography

Personal History

Dr Gregg Curtis Fonarow is a Cardiologist and Professor based in the Los Angeles area. 

 

Academic History

In 1987, he obtained his M.D. from the University of California Los Angeles David Geffen School of Medicine. He then completed his internship, residency and fellowship between 1988-1993 at the UCLA School of Medicine.1

His research interests centre on heart failure management, preventative cardiology, disease management and implementing treatment systems to improve clinical outcome.1

 

Career Overview

Dr Fonarow serves as Co-Chief of UCLA's Division of Cardiology, Director of the Ahmanson-UCLA Cardiomyopathy Center, and Co-director of UCLA's Preventative Cardiology Program.1, 2

In 2003, he became Professor of Medicine and was awarded the Eliot Corday Chair in Cardiovascular Medicine and Science. He has also developed and successfully implemented a comprehensive atherosclerosis treatment program at the UCLA Medical Center (Cardiovascular Hospitalization Atherosclerosis Management Program: CHAMP).1

Dr Fonarow is on the steering committee for the American Heart Association's Get with the Guidelines (GWTG) program, ADHERE Registries, and OPTIMIZE-HF. He serves as a reviewer and on the editorial boards of a number of leading cardiovascular journals. He has published over 1400 research studies and clinical trials in heart failure management, preventative cardiology, and outcomes research.1

 

Career Timeline

  • UCLA Medical Center
    • 2013 - Present: Clinical Co-Chief, Cardiology
    • Present: Professor, Cardiovascular Medicine and Science
    • Present: Director, Ahmanson-UCLA Cardiomyopathy Center
    • Present: Co-Director, Preventative Cardiology Program

 

Areas of Speciality

  • Heart Failure Management
  • Cardiomyopathy
  • Preventive Cardiology
  • Disease Management
  • Quality of Care/Outcomes

 

Recognitions

  • 2014 - 2020: Clarivate Highly Cited Researchers
  • 2015: World's Most Influential Scientific Minds
  • 2015: Clinical Research Forum Distinguished Clinical Research Award
  • 2019: Outstanding Lifetime Achievement Award, AHA Quality of Care and Outcomes Research Council
  • 2017: American Heart Association National Chairman's Award
  • 2009: Raymond D. Bahr Award of Excellence and the Turning Guidelines into Lifelines Award from the AHA
  • 2004: AHA Award of Meritorious Achievement
  • 1998: W. Proctor Harvey Young Teacher Award, American College of Cardiology
  • 1997: Outstanding UCLA Cardiology Faculty Teaching Award

 

Sources

  1. https://www.uclahealth.org/providers/gregg-fonarow 
  2. https://www.cardiometabolichealth.org/faculty/gregg-c-fonarow/ 

 

Articles by Gregg C Fonarow, Professor and Clinical Co-Chief of Cardiology

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction

Nicholas K Brownell, Boback Ziaeian, Gregg C Fonarow, et al

Published:

Citation: Cardiac Failure Review 2021;7:e18.

Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization

Neal M Dixit, Shivani Shah, Boback Ziaeian, et al

Published:

Citation: US Cardiology Review 2021;15:e07.

Gaps in the Heart Failure Guidelines

Bao Tran, Gregg C Fonarow,

Citation: European Cardiology Review 2014;9(2):104–9

Gaps in the Heart Failure Guidelines

Bao Tran, Gregg C Fonarow,

Published:

Citation: Cardiac Failure Review 2015;1(1):50–5